← 產業報告目錄

Flow Cytometry Market by Technology (Cell-based, Bead-Based), Product & Service (Analyzer, Sorter, Consumables (Antibodies, Assays, Kits), Software), Application (Research (Stem Cell), Clinical (Cancer)), End User (Hospital) - Global Forecast to 2033

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-08-11頁數 511報告編號 BT6015

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global flow cytometry market is estimated to reach USD 9.85 billion by 2033 from USD 5.06 billion in 2025, at a CAGR of 8.7% during the forecast period. Advancements in reagent technologies, such as fluorophore conjugation and specificity enhancement, are one of the major factors driving the market. This segment dominates due to continuous demand for antibodies, dyes, and other consumables essential for cell analysis. As the use of flow cytometry expands in research, clinical diagnostics, and drug development, the need for high-quality reagents remains constant. “The cell-based flow cytometry market is likely to grow at a faster pace.” Based on technology, the flow cytometry market is segmented into cell-based and bead-based flow cytometry. The cell-based flow cytometry segment dominated the market in 2024. The dominance of cell-based flow cytometry in the technology segment is attributed to its versatility in analyzing various cell types and biomarkers. Cell-based flow cytometry provides both quantitative and qualitative data that has increased its demand in biomedical research, clinical diagnostics, and drug discovery, thus driving its market significance. “The research application dominated the applications market segment.” Based on application, the flow cytometry market is segmented into research applications, clinical applications, and industrial applications. The research application dominated the segment; however, clinical application is anticipated to grow at a significant CAGR during the forecast period. The extensive use of flow cytometry in basic and translational research across diverse fields such as immunology, oncology, and microbiology is likely to drive the segmental growth. “The market in Asia Pacific is estimated to witness the fastest growth rate.” Based on region, the flow cytometry market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2024, North America accounted for a major share of the flow cytometry market. The Asia Pacific region is likely to grow at a significant CAGR during the forecast period, owing to various factors such as increasing investment in healthcare infrastructure, rising R&D activities in life sciences, and growing awareness about personalized medicine, which are driving this growth. Moreover, countries like China, Japan, India, and South Korea are witnessing substantial adoption of flow cytometry technologies in research, clinical diagnostics, and drug discovery. The primary interviews conducted for this report can be categorized as follows: • By Respondent: Tier 1 - 25%, Tier 2 - 35%, and Tier 3 - 40% • By Designation: C-level Executives - 30%, Directors - 45%, and Others - 25% • By Region: North America - 35%, Europe - 25%, Asia Pacific - 15%, Latin America - 10%, Middle East - 10%, and Africa - 5% List of Companies Profiled in the Report: • Becton, Dickinson and Company (US) • Danaher Corporation (US) • Thermo Fisher Scientific Inc. (US) • Agilent Technologies, Inc. (US) • Sony Corporation (Japan) • Bio-Rad Laboratories, Inc. (US) • Miltenyi Biotec (Germany) • Enzo Biochem, Inc. (US) • Sysmex Corporation (Japan) • bioMérieux (France) • Cytonome/ST, LLC (US) • Sartorius AG (Germany) • Cytek Biosciences (US) • Union Biometrica, Inc. (US) • Takara Bio Inc. (Japan) Research Coverage: This research report categorizes flow cytometry market by Offering (Reagents and Consumables, Instruments, Services, Software, and Accessories), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Pharmaceutical & Biotechnology Companies, Hospitals & Clinical Testing Laboratories, And Academic & Research Institutes), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The report's scope covers detailed information regarding the primary factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the flow cytometry market. A thorough analysis of the key industry players has been conducted to provide insights into their business overview, solutions, and services; key strategies; new product & service launches, acquisitions, and recent developments associated with the flow cytometry market. This report covers the competitive analysis of upcoming startups in the flow cytometry market ecosystem. Key Benefits of Buying the Report: The report will help market leaders/new entrants by providing them with the estimations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges. The report provides insights on the following pointers: • Analysis of key drivers (Increasing prevalence of chronic diseases, growing use of flow cytometry in regenerative medicines, increasing collaborations, strategic partnerships, and alliances among key players, launch of technologically advanced flow cytometry products), restraints (High cost of advanced flow cytometers ), opportunities (Increased use in clinical applications and infectious disease diagnostics), and challenges (Complexities related to reagent development) influencing the growth of the market. • Product Development/Innovation: Detailed insights on newly launched products and technological assessment of the flow cytometry market • Market Development: Comprehensive information about lucrative markets and analysis of the market across varied regions • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the flow cytometry market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players, including Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, among others, offering products and services for flow cytometry market. Other companies include Apogee Flow Systems Ltd. (UK), Stratedigm, Inc. (US), NanoCellect Biomedical, Inc. (US), and On-chip Biotechnologies, Co., Ltd. (Japan), among others, for the flow cytometry market.
目錄 Table of Contents
1 INTRODUCTION 44 1.1 STUDY OBJECTIVES 44 1.2 MARKET DEFINITION 45 1.2.1 INCLUSIONS AND EXCLUSIONS 45 1.3 STUDY SCOPE 46 1.3.1 SEGMENTS COVERED 46 1.3.2 YEARS CONSIDERED 47 1.3.3 CURRENCY CONSIDERED 47 1.4 STAKEHOLDERS 47 1.5 SUMMARY OF CHANGES 48 2 RESEARCH METHODOLOGY 49 2.1 RESEARCH DATA 49 2.1.1 SECONDARY DATA 49 2.1.2 PRIMARY DATA 50 2.1.2.1 Breakdown of primaries 51 2.2 MARKET SIZE ESTIMATION 52 2.2.1 GLOBAL MARKET SIZE ESTIMATION 52 2.2.2 SEGMENTAL MARKET ASSESSMENT 55 2.3 MARKET GROWTH RATE PROJECTION 57 2.3.1 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS 58 2.4 DATA TRIANGULATION 59 2.5 RESEARCH ASSUMPTIONS 60 2.6 RESEARCH LIMITATIONS 61 2.7 RISK ANALYSIS 61 3 EXECUTIVE SUMMARY 62 4 PREMIUM INSIGHTS 66 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN FLOW CYTOMETRY MARKET 66 4.2 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY 67 4.3 FLOW CYTOMETRY MARKET SHARE, BY END USER, 2024 67 4.4 FLOW CYTOMETRY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 68   5 MARKET OVERVIEW 69 5.1 INTRODUCTION 69 5.2 MARKET DYNAMICS 69 5.2.1 DRIVERS 70 5.2.1.1 Increase in demand for flow cytometry in oncology research & diagnostics 70 5.2.1.2 Growing use of flow cytometry in regenerative medicines 71 5.2.1.3 Increasing collaborations, strategic partnerships, and alliances among key players 72 5.2.1.4 Launch of technologically advanced flow cytometry products 73 5.2.2 RESTRAINTS 74 5.2.2.1 High cost of advanced flow cytometers (analyzers & cell sorters) 74 5.2.3 OPPORTUNITIES 75 5.2.3.1 Increased use in clinical applications and infectious disease diagnostics 75 5.2.4 CHALLENGES 75 5.2.4.1 Complexities related to reagent development 75 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 76 5.4 PRICING ANALYSIS 76 5.4.1 AVERAGE SELLING PRICE TREND OF FLOW CYTOMETRY PRODUCTS, BY KEY PLAYER, 2022–2024 77 5.4.2 AVERAGE SELLING PRICE TREND OF FLOW CYTOMETRY PRODUCTS, BY REGION, 2022–2024 79 5.5 VALUE CHAIN ANALYSIS 80 5.6 ECOSYSTEM ANALYSIS 82 5.6.1 INSTRUMENT & SOFTWARE PROVIDERS 82 5.6.2 REAGENT & CONSUMABLE PROVIDERS 82 5.6.3 END USERS 82 5.6.4 REGULATORY BODIES 82 5.7 REGULATORY ANALYSIS 84 5.7.1 REGULATORY LANDSCAPE 84 5.7.1.1 Stringent FDA requirements 84 5.7.1.2 Analyte-specific reagent rules 84 5.7.1.3 Limitations in validation protocols for cell-based assays 85 5.7.1.4 Absence of test guidelines for cell-based fluorescence assays 85 5.7.1.5 IVD CE mark approvals 85 5.7.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85 5.7.2.1 North America: List of regulatory bodies, government agencies, and other organizations 85 5.7.2.2 Europe: List of regulatory bodies, government agencies, and other organizations 86 5.7.2.3 Asia Pacific: List of regulatory bodies, government agencies, and other organizations 87 5.7.2.4 Latin America: List of regulatory bodies, government agencies, and other organizations 88 5.7.2.5 Middle East & Africa: List of regulatory bodies, government agencies, and other organizations 88 5.8 PORTER’S FIVE FORCES ANALYSIS 89 5.8.1 INTENSITY OF COMPETITIVE RIVALRY 90 5.8.2 BARGAINING POWER OF SUPPLIERS 90 5.8.3 BARGAINING POWER OF BUYERS 90 5.8.4 THREAT OF SUBSTITUTES 90 5.8.5 THREAT OF NEW ENTRANTS 91 5.9 KEY STAKEHOLDERS AND BUYING CRITERIA 91 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS 92 5.9.2 KEY BUYING CRITERIA 93 5.10 TECHNOLOGY ANALYSIS 94 5.10.1 KEY TECHNOLOGIES 94 5.10.1.1 Spectral flow cytometry 94 5.10.1.2 Mass cytometry 94 5.10.1.3 Imaging flow cytometry 95 5.10.2 ADJACENT TECHNOLOGIES 95 5.10.2.1 Single-cell RNA sequencing 95 5.10.2.2 Microfluidics 95 5.10.2.3 High-content screening 95 5.10.3 COMPLEMENTARY TECHNOLOGIES 96 5.10.3.1 Single-cell analysis 96 5.10.3.2 Spatial analysis 96 5.11 PATENT ANALYSIS 96 5.11.1 METHODOLOGY 96 5.11.2 PATENTS FILED, BY DOCUMENT TYPE, 2014−2024 96 5.12 TRADE DATA ANALYSIS 98 5.12.1 IMPORT DATA 98 5.12.2 EXPORT DATA 99 5.13 INVESTMENT AND FUNDING SCENARIO 99 5.14 KEY CONFERENCES AND EVENTS, 2025–2026 101 5.15 IMPACT OF 2025 US TARIFF: FLOW CYTOMETRY MARKET 102 5.15.1 KEY TARIFF RATES 102 5.15.2 PRICE IMPACT ANALYSIS 104 5.15.3 KEY IMPACTS ON VARIOUS REGIONS 105 5.15.3.1 US 105 5.15.3.2 Europe 105 5.15.3.3 Asia Pacific 106   5.15.4 END-USE INDUSTRY IMPACT 106 5.15.4.1 Pharmaceutical and biotech companies 106 5.15.4.2 Hospitals & clinical laboratories 107 5.15.4.3 Academic & research institutes 107 5.16 IMPACT OF AI/GEN AI ON FLOW CYTOMETRY MARKET 107 5.16.1 MARKET POTENTIAL OF AI IN FLOW CYTOMETRY 107 5.16.2 AI USE CASES 108 5.16.3 KEY COMPANIES IMPLEMENTING AI/GEN AI 108 5.16.4 FUTURE OF AI/GEN AI IN FLOW CYTOMETRY MARKET 108 6 FLOW CYTOMETRY MARKET, BY OFFERING 110 6.1 INTRODUCTION 111 6.2 REAGENTS & CONSUMABLES 111 6.2.1 ANTIBODIES 115 6.2.1.1 Increasing demand for high-specificity antibodies to propel market growth 115 6.2.2 ASSAYS & KITS 119 6.2.2.1 Need for high-precision diagnosis and advancements in personalized medicines to aid market growth 119 6.2.3 OTHER REAGENTS & CONSUMABLES 122 6.3 INSTRUMENTS 125 6.3.1 CELL ANALYZERS 129 6.3.1.1 High-range cell analyzers 133 6.3.1.1.1 Better sensitivity, accuracy, and flexibility in designing multicolor experiments to augment segment growth 133 6.3.1.2 Mid-range cell analyzers 136 6.3.1.2.1 Availability of compact and high-performance analyzers to support market growth 136 6.3.1.3 Low-range cell analyzers 139 6.3.1.3.1 Cost-effectiveness and increased commercialization by manufacturers to drive segment 139 6.3.2 CELL SORTERS 142 6.3.2.1 High-range cell sorters 146 6.3.2.1.1 High cost and budget constraints among end users to limit market growth 146 6.3.2.2 Mid-range cell sorters 149 6.3.2.2.1 Cost-effectiveness and high availability to spur market growth 149 6.3.2.3 Low-range cell sorters 152 6.3.2.3.1 Increasing commercialization in small-scale laboratories and research facilities to fuel market growth 152 6.4 SERVICES 155 6.4.1 RISING FOCUS ON WORKFLOW CONTINUITY AND PERFORMANCE MAXIMIZATION TO BOOST MARKET GROWTH 155   6.5 SOFTWARE 158 6.5.1 INCREASING AVAILABILITY OF DATA ANALYSIS SOFTWARE TO AID MARKET GROWTH 158 6.6 ACCESSORIES 162 6.6.1 HIGH AVAILABILITY OF ADVANCED AND CUSTOMIZED ACCESSORIES TO SUPPORT MARKET GROWTH 162 7 FLOW CYTOMETRY MARKET, BY TECHNOLOGY 166 7.1 INTRODUCTION 167 7.2 CELL-BASED FLOW CYTOMETRY 167 7.2.1 INCREASED FOCUS ON R&D AND TECHNOLOGICAL ADVANCEMENTS TO PROPEL MARKET GROWTH 167 7.3 BEAD-BASED FLOW CYTOMETRY 171 7.3.1 HIGHER RELIABILITY AND BETTER MEASUREMENT CONSISTENCIES TO SUPPORT MARKET GROWTH 171 8 FLOW CYTOMETRY MARKET, BY APPLICATION 175 8.1 INTRODUCTION 176 8.2 RESEARCH APPLICATIONS 176 8.2.1 DRUG DISCOVERY AND DEVELOPMENT 180 8.2.1.1 Drug discovery 184 8.2.1.1.1 Growing use of phenotypic cell-based assays to support market growth 184 8.2.1.2 Stem cell research 188 8.2.1.2.1 Increasing R&D and rising investments for advanced stem cell development to drive segment 188 8.2.1.3 In vitro toxicity testing 192 8.2.1.3.1 Focus on continuous drug development by pharmaceutical & biotechnology companies to aid segment growth 192 8.2.2 IMMUNOLOGY 195 8.2.2.1 Growing prevalence of chronic autoimmune diseases to drive market 195 8.2.3 CELL SORTING 199 8.2.3.1 Increasing focus on cell-based research activities to fuel market growth 199 8.2.4 APOPTOSIS 203 8.2.4.1 Increased use in research activities to drive segment 203 8.2.5 CELL CYCLE ANALYSIS 206 8.2.5.1 High accuracy of cytometry products in cell analysis to propel segment growth 206 8.2.6 CELL VIABILITY 210 8.2.6.1 Growing use of cell viability assays in research to support market growth 210 8.2.7 CELL COUNTING 213 8.2.7.1 Rising need for multi-parametric cellular assessments to spur market growth 213 8.2.8 OTHER RESEARCH APPLICATIONS 217 8.3 CLINICAL APPLICATIONS 220 8.3.1 CANCER DIAGNOSTICS 224 8.3.1.1 Increasing prevalence of cancer to drive segment 224 8.3.2 HEMATOLOGY 228 8.3.2.1 Multi-parametric approach and high-speed cell analyzing capabilities to augment segment growth 228 8.3.3 AUTOIMMUNE DISEASES 231 8.3.3.1 Growing focus on developing treatments for autoimmune diseases to drive segment 231 8.3.4 ORGAN TRANSPLANTATION 235 8.3.4.1 Rising number of organ transplants to propel market growth 235 8.3.5 OTHER CLINICAL APPLICATIONS 239 8.4 INDUSTRIAL APPLICATIONS 242 8.4.1 INCREASING USE IN FOOD, DAIRY, ENERGY, AND MICROBIAL INDUSTRIES TO SUPPORT MARKET GROWTH 242 9 FLOW CYTOMETRY MARKET, BY END USER 247 9.1 INTRODUCTION 248 9.2 ACADEMIC & RESEARCH INSTITUTES 248 9.2.1 RISING PUBLIC-PRIVATE FUNDING AND INCREASING CANCER RESEARCH PROJECTS TO DRIVE MARKET 248 9.3 HOSPITALS & CLINICAL TESTING LABORATORIES 253 9.3.1 GROWING DEMAND FOR EFFECTIVE DISEASE DIAGNOSIS AND TREATMENT TO SPUR MARKET GROWTH 253 9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 257 9.4.1 INCREASING FOCUS ON PERSONALIZED MEDICINE AND TARGETED THERAPIES TO FUEL MARKET GROWTH 257 10 FLOW CYTOMETRY MARKET, BY REGION 261 10.1 INTRODUCTION 262 10.2 NORTH AMERICA 263 10.2.1 MACROECONOMIC OUTLOOK 263 10.2.2 US 269 10.2.2.1 US to dominate North American flow cytometry market during study period 269 10.2.3 CANADA 274 10.2.3.1 Ongoing government initiatives for life science research and high incidence of cancer to propel market growth 274 10.3 EUROPE 279 10.3.1 MACROECONOMIC OUTLOOK 280 10.3.2 GERMANY 286 10.3.2.1 Increasing public and private funding for advanced cell-based research activities to aid market growth 286   10.3.3 UK 290 10.3.3.1 Growing acceptance of flow cytometry-based diagnostic techniques by healthcare professionals to spur market growth 290 10.3.4 FRANCE 295 10.3.4.1 Increasing government funding for proteomics and genomics research to fuel market growth 295 10.3.5 ITALY 301 10.3.5.1 Large geriatric population and presence of well-developed healthcare system to boost market growth 301 10.3.6 SPAIN 305 10.3.6.1 High incidence of cancer and focus on translational and personalized medicines to augment market growth 305 10.3.7 REST OF EUROPE 310 10.4 ASIA PACIFIC 316 10.4.1 MACROECONOMIC OUTLOOK 316 10.4.2 CHINA 322 10.4.2.1 High incidence of cancer and favorable government policies to support market growth 322 10.4.3 JAPAN 327 10.4.3.1 Technological advancements and high prevalence of chronic diseases to drive market 327 10.4.4 INDIA 332 10.4.4.1 Rising government funding for proteomics research to drive market 332 10.4.5 AUSTRALIA 338 10.4.5.1 Increasing government research funding and growing prevalence of cancer to propel market growth 338 10.4.6 SOUTH KOREA 343 10.4.6.1 Rising number of conferences and growing focus on medical research to spur market growth 343 10.4.7 SINGAPORE 348 10.4.7.1 Increasing availability of data analysis software and growing focus on medical tourism to drive market 348 10.4.8 INDONESIA 354 10.4.8.1 Rising prevalence of HIV and cancer to drive market 354 10.4.9 REST OF ASIA PACIFIC 359 10.5 LATIN AMERICA 364 10.5.1 MACROECONOMIC OUTLOOK 365 10.5.2 BRAZIL 370 10.5.2.1 Presence of key market players and increased emphasis on cancer research to boost market growth 370 10.5.3 MEXICO 375 10.5.3.1 Favorable trade agreements and growth of pharmaceutical industry to fuel market growth 375 10.5.4 REST OF LATIN AMERICA 380   10.6 MIDDLE EAST 385 10.6.1 MACROECONOMIC OUTLOOK 385 10.6.2 GCC COUNTRIES 391 10.6.2.1 Saudi Arabia 395 10.6.2.1.1 Growing prevalence of chronic diseases and increasing R&D investments to boost market growth 395 10.6.2.2 UAE 400 10.6.2.2.1 Increased R&D investment and favorable government healthcare policies to drive market 400 10.6.2.3 Rest of GCC countries 405 10.6.3 REST OF MIDDLE EAST 410 10.7 AFRICA 416 10.7.1 INCREASING BURDEN OF INFECTIOUS AND NON-COMMUNICABLE DISEASES TO PROPEL MARKET GROWTH 416 10.7.2 MACROECONOMIC OUTLOOK 416 11 COMPETITIVE LANDSCAPE 422 11.1 OVERVIEW 422 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN 422 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN FLOW CYTOMETRY MARKET 422 11.3 REVENUE ANALYSIS 424 11.4 MARKET SHARE ANALYSIS 425 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 427 11.5.1 STARS 427 11.5.2 EMERGING LEADERS 427 11.5.3 PERVASIVE PLAYERS 427 11.5.4 PARTICIPANTS 427 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 429 11.5.5.1 Company footprint 429 11.5.5.2 Product & service footprint 430 11.5.5.3 Region footprint 431 11.5.5.4 Application footprint 432 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 432 11.6.1 PROGRESSIVE COMPANIES 432 11.6.2 RESPONSIVE COMPANIES 432 11.6.3 DYNAMIC COMPANIES 433 11.6.4 STARTING BLOCKS 433 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 434 11.7 VALUATION & FINANCIAL METRICS 436 11.7.1 VALUATION OF KEY PLAYERS 436 11.7.2 FINANCIAL METRICS OF KEY PLAYERS 436   11.8 BRAND/PRODUCT COMPARISON 437 11.9 COMPETITIVE SCENARIO 439 11.9.1 PRODUCT LAUNCHES & APPROVALS 439 11.9.2 DEALS 440 12 COMPANY PROFILES 441 12.1 KEY PLAYERS 441 12.1.1 BECTON, DICKINSON AND COMPANY 441 12.1.1.1 Business overview 441 12.1.1.2 Products/Services offered 442 12.1.1.3 Recent developments 446 12.1.1.3.1 Product launches 446 12.1.1.3.2 Deals 447 12.1.1.4 MnM view 447 12.1.1.4.1 Right to win 447 12.1.1.4.2 Strategic choices 447 12.1.1.4.3 Weaknesses & competitive threats 448 12.1.2 DANAHER CORPORATION 449 12.1.2.1 Business overview 449 12.1.2.2 Products/Services offered 451 12.1.2.3 Recent developments 453 12.1.2.3.1 Product launches 453 12.1.2.3.2 Deals 453 12.1.2.4 MnM view 454 12.1.2.4.1 Right to win 454 12.1.2.4.2 Strategic choices 454 12.1.2.4.3 Weaknesses & competitive threats 454 12.1.3 THERMO FISHER SCIENTIFIC INC. 455 12.1.3.1 Business overview 455 12.1.3.2 Products/Services offered 456 12.1.3.3 Recent developments 457 12.1.3.3.1 Product launches 457 12.1.3.3.2 Deals 458 12.1.3.4 MnM view 458 12.1.3.4.1 Right to win 458 12.1.3.4.2 Strategic choices 458 12.1.3.4.3 Weaknesses & competitive threats 458 12.1.4 AGILENT TECHNOLOGIES, INC. 459 12.1.4.1 Business overview 459 12.1.4.2 Products/Services offered 461 12.1.4.3 Recent developments 462 12.1.4.3.1 Product launches 462 12.1.5 SONY CORPORATION 463 12.1.5.1 Business overview 463 12.1.5.2 Products/Services offered 464 12.1.5.3 Recent developments 466 12.1.5.3.1 Product launches 466 12.1.5.3.2 Deals 466 12.1.6 BIO-RAD LABORATORIES, INC. 467 12.1.6.1 Business overview 467 12.1.6.2 Products/Services/Solutions offered 468 12.1.6.3 Recent developments 469 12.1.6.3.1 Product launches 469 12.1.7 MILTENYI BIOTEC 470 12.1.7.1 Business overview 470 12.1.7.2 Products/Services offered 470 12.1.8 ENZO BIOCHEM INC. 472 12.1.8.1 Business overview 472 12.1.8.2 Products/Services offered 473 12.1.9 SYSMEX CORPORATION 475 12.1.9.1 Business overview 475 12.1.9.2 Products/Services offered 477 12.1.9.3 Recent developments 477 12.1.9.3.1 Product launches 477 12.1.10 CYTEK BIOSCIENCES 478 12.1.10.1 Business overview 478 12.1.10.2 Products/Services offered 480 12.1.10.3 Recent developments 481 12.1.10.3.1 Product launches 481 12.1.10.3.2 Deals 481 12.1.11 BIOMÉRIEUX 483 12.1.11.1 Business overview 483 12.1.11.2 Products/Services offered 484 12.1.12 CYTONOME/ST, LLC 485 12.1.12.1 Business overview 485 12.1.12.2 Products/Services offered 485 12.1.13 SARTORIUS AG 486 12.1.13.1 Business overview 486 12.1.13.2 Products/Services offered 487 12.1.14 UNION BIOMETRICA, INC. 488 12.1.14.1 Business overview 488 12.1.14.2 Products/Services offered 488 12.1.15 TAKARA BIO INC. 489 12.1.15.1 Business overview 489 12.1.15.2 Products/Services offered 491 12.2 OTHER PLAYERS 492 12.2.1 APOGEE FLOW SYSTEMS LTD. 492 12.2.2 STRATEDIGM, INC. 493 12.2.3 NANOCELLECT BIOMEDICAL 494 12.2.4 BIOLEGEND, INC. 495 12.2.5 ON-CHIP BIOTECHNOLOGIES CO., LTD. 496 12.2.6 NEXCELOM BIOSCIENCE LLC 497 12.2.7 BENNUBIO INC. 498 12.2.8 ORFLO TECHNOLOGIES 499 12.2.9 BAY BIOSCIENCE LLC 500 12.2.10 CYTOBUOY 500 13 APPENDIX 501 13.1 DISCUSSION GUIDE 501 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 507 13.3 CUSTOMIZATION OPTIONS 509 13.4 RELATED REPORTS 509 13.5 AUTHOR DETAILS 510
圖表清單 List of Tables & Figures
TABLE 1 FLOW CYTOMETRY MARKET: INCLUSIONS AND EXCLUSIONS 45 TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS IN FLOW CYTOMETRY MARKET 58 TABLE 3 FLOW CYTOMETRY MARKET: RISK ANALYSIS 61 TABLE 4 INCIDENCE OF HIV/AIDS GLOBALLY, BY REGION, 2023 70 TABLE 5 GLOBAL INCIDENCE OF CANCER, BY REGION, 2022 70 TABLE 6 ESTIMATED EXPENDITURE BY NATIONAL INSTITUTES OF HEALTH FOR STEM CELL RESEARCH, 2019–2024 72 TABLE 7 KEY PRODUCT LAUNCHES IN FLOW CYTOMETRY MARKET, JANUARY 2021–MAY 2025 73 TABLE 8 AVERAGE SELLING PRICE TREND OF FLOW CYTOMETRY PRODUCTS, BY KEY PLAYER, 2022–2024 (USD MILLION) 77 TABLE 9 AVERAGE SELLING PRICE TREND OF FLOW CYTOMETRY REAGENTS AND CONSUMABLES, BY REGION, 2022–2024 (USD MILLION) 79 TABLE 10 AVERAGE SELLING PRICE TREND OF FLOW CYTOMETRY INSTRUMENTS, BY REGION, 2022–2024 (USD MILLION) 79 TABLE 11 FLOW CYTOMETRY MARKET: ROLE IN ECOSYSTEM 83 TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85 TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86 TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87 TABLE 15 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 TABLE 16 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 TABLE 17 FLOW CYTOMETRY MARKET: PORTER’S FIVE FORCES ANALYSIS 89 TABLE 18 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 92 TABLE 19 KEY BUYING CRITERIA, BY END USER 93 TABLE 20 PATENTS FILED (2014−2024) 96 TABLE 21 PATENTS IN FLOW CYTOMETRY MARKET 97 TABLE 22 IMPORT VALUE OF HS CODE 9027.50–COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (USD THOUSAND) 98 TABLE 23 EXPORT VALUE OF HS CODE 9027.50 – COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020–2024 (USD THOUSAND) 99 TABLE 24 MAJOR INVESTMENT AND FUNDING ACTIVITIES IN FLOW CYTOMETRY MARKET, 2022–2025 100 TABLE 25 FLOW CYTOMETRY MARKET: LIST OF KEY CONFERENCES AND EVENTS, JANUARY 2025–DECEMBER 2026 101 TABLE 26 US ADJUSTED RECIPROCAL TARIFF RATES 102 TABLE 27 EXPORTS AND IMPORTS, BY REGION 103 TABLE 28 KEY PRODUCT-RELATED TARIFF: INSTRUMENTS AND APPARATUS; PARTS AND ACCESSORIES THEREOF, MISCELLANEOUS CHEMICAL PRODUCTS 104 TABLE 29 CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES 105 TABLE 30 LIST OF COMPANIES IMPLEMENTING AI/GEN AI IN FLOW CYTOMETRY MARKET 108 TABLE 31 FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 111 TABLE 32 FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 112 TABLE 33 FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2023–2033 (USD MILLION) 112 TABLE 34 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2023–2033 (USD MILLION) 113 TABLE 35 EUROPE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2023–2033 (USD MILLION) 113 TABLE 36 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2023–2033 (USD MILLION) 114 TABLE 37 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2023–2033 (USD MILLION) 114 TABLE 38 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2023–2033 (USD MILLION) 114 TABLE 39 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2023–2033 (USD MILLION) 115 TABLE 40 ANTIBODIES MARKET, BY REGION, 2023–2033 (USD MILLION) 116 TABLE 41 NORTH AMERICA: ANTIBODIES MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 116 TABLE 42 EUROPE: ANTIBODIES MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 117 TABLE 43 ASIA PACIFIC: ANTIBODIES MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 117 TABLE 44 LATIN AMERICA: ANTIBODIES MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 118 TABLE 45 MIDDLE EAST: ANTIBODIES MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 118 TABLE 46 GCC COUNTRIES: ANTIBODIES MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 118 TABLE 47 ASSAYS & KITS MARKET, BY REGION, 2023–2033 (USD MILLION) 119 TABLE 48 NORTH AMERICA: ASSAYS & KITS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 120 TABLE 49 EUROPE: ASSAYS & KITS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 120 TABLE 50 ASIA PACIFIC: ASSAYS & KITS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 120 TABLE 51 LATIN AMERICA: ASSAYS & KITS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 121 TABLE 52 MIDDLE EAST: ASSAYS & KITS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 121 TABLE 53 GCC COUNTRIES: ASSAYS & KITS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 121 TABLE 54 OTHER REAGENTS & CONSUMABLES MARKET, BY REGION, 2023–2033 (USD MILLION) 122 TABLE 55 NORTH AMERICA: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 123 TABLE 56 EUROPE: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 123 TABLE 57 ASIA PACIFIC: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 124 TABLE 58 LATIN AMERICA: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 124 TABLE 59 MIDDLE EAST: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 124 TABLE 60 GCC COUNTRIES: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 125 TABLE 61 FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 126 TABLE 62 FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY REGION, 2023–2033 (USD MILLION) 126 TABLE 63 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2033 (USD MILLION) 126 TABLE 64 EUROPE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2033 (USD MILLION) 127 TABLE 65 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2033 (USD MILLION) 127 TABLE 66 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2033 (USD MILLION) 128 TABLE 67 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2033 (USD MILLION) 128 TABLE 68 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2033 (USD MILLION) 128 TABLE 69 CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 130 TABLE 70 CELL ANALYZERS MARKET, BY REGION, 2023–2033 (USD MILLION) 130 TABLE 71 NORTH AMERICA: CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 130 TABLE 72 EUROPE: CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 131 TABLE 73 ASIA PACIFIC: CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 131 TABLE 74 LATIN AMERICA: CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 132 TABLE 75 MIDDLE EAST: CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 132 TABLE 76 GCC COUNTRIES: CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 132 TABLE 77 HIGH-RANGE CELL ANALYZERS MARKET, BY REGION, 2023–2033 (USD MILLION) 133 TABLE 78 NORTH AMERICA: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 133 TABLE 79 EUROPE: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 134 TABLE 80 ASIA PACIFIC: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 134 TABLE 81 LATIN AMERICA: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 135 TABLE 82 MIDDLE EAST: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 135 TABLE 83 GCC COUNTRIES: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 135 TABLE 84 MID-RANGE CELL ANALYZERS MARKET, BY REGION, 2023–2033 (USD MILLION) 136 TABLE 85 NORTH AMERICA: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 136 TABLE 86 EUROPE: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 137 TABLE 87 ASIA PACIFIC: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 137 TABLE 88 LATIN AMERICA: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 138 TABLE 89 MIDDLE EAST: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 138 TABLE 90 GCC COUNTRIES: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 138 TABLE 91 LOW-RANGE CELL ANALYZERS MARKET, BY REGION, 2023–2033 (USD MILLION) 139 TABLE 92 NORTH AMERICA: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 139 TABLE 93 EUROPE: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 140 TABLE 94 ASIA PACIFIC: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 140 TABLE 95 LATIN AMERICA: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 141 TABLE 96 MIDDLE EAST: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 141 TABLE 97 GCC COUNTRIES: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 141 TABLE 98 LIST OF KEY CELL SORTERS AVAILABLE IN MARKET 142 TABLE 99 CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 143 TABLE 100 CELL SORTERS MARKET, BY REGION, 2023–2033 (USD MILLION 143 TABLE 101 NORTH AMERICA: CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 143 TABLE 102 EUROPE: CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 144 TABLE 103 ASIA PACIFIC: CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 144 TABLE 104 LATIN AMERICA: CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 145 TABLE 105 MIDDLE EAST: CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 145 TABLE 106 GCC COUNTRIES: CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 145 TABLE 107 HIGH-RANGE CELL SORTERS MARKET, BY REGION, 2023–2033 (USD MILLION) 146 TABLE 108 NORTH AMERICA: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 146 TABLE 109 EUROPE: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 147 TABLE 110 ASIA PACIFIC: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 147 TABLE 111 LATIN AMERICA: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 148 TABLE 112 MIDDLE EAST: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 148 TABLE 113 GCC COUNTRIES: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 148 TABLE 114 MID-RANGE CELL SORTERS MARKET, BY REGION, 2023–2033 (USD MILLION) 149 TABLE 115 NORTH AMERICA: MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 149 TABLE 116 EUROPE: MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 150 TABLE 117 ASIA PACIFIC: MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 150 TABLE 118 LATIN AMERICA: MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 151 TABLE 119 MIDDLE EAST: MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 151 TABLE 120 GCC COUNTRIES: MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 151 TABLE 121 LOW-RANGE CELL SORTERS MARKET, BY REGION, 2023–2033 (USD MILLION) 152 TABLE 122 NORTH AMERICA: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 152 TABLE 123 EUROPE: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 153 TABLE 124 ASIA PACIFIC: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 153 TABLE 125 LATIN AMERICA: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 154 TABLE 126 MIDDLE EAST: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 154 TABLE 127 GCC COUNTRIES: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 154 TABLE 128 FLOW CYTOMETRY MARKET FOR SERVICES, BY REGION, 2023–2033 (USD MILLION) 155 TABLE 129 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2023–2033 (USD MILLION) 156 TABLE 130 EUROPE: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2023–2033 (USD MILLION) 156 TABLE 131 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2023–2033 (USD MILLION) 157 TABLE 132 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2023–2033 (USD MILLION) 157 TABLE 133 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2023–2033 (USD MILLION) 158 TABLE 134 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2023–2033 (USD MILLION) 158 TABLE 135 FLOW CYTOMETRY MARKET FOR SOFTWARE, BY REGION, 2023–2033 (USD MILLION) 159 TABLE 136 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2023–2033 (USD MILLION) 160 TABLE 137 EUROPE: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2023–2033 (USD MILLION) 160 TABLE 138 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2023–2033 (USD MILLION) 161 TABLE 139 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2023–2033 (USD MILLION) 161 TABLE 140 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2023–2033 (USD MILLION) 162 TABLE 141 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2023–2033 (USD MILLION) 162 TABLE 142 FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY REGION, 2023–2033 (USD MILLION) 163 TABLE 143 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2023–2033 (USD MILLION) 163 TABLE 144 EUROPE: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2023–2033 (USD MILLION) 164 TABLE 145 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2023–2033 (USD MILLION) 164 TABLE 146 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2023–2033 (USD MILLION) 165 TABLE 147 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2023–2033 (USD MILLION) 165 TABLE 148 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2023–2033 (USD MILLION) 165 TABLE 149 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 167 TABLE 150 CELL-BASED FLOW CYTOMETRY MARKET, BY REGION, 2023–2033 (USD MILLION) 168 TABLE 151 NORTH AMERICA: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 168 TABLE 152 EUROPE: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 169 TABLE 153 ASIA PACIFIC: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 169 TABLE 154 LATIN AMERICA: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 170 TABLE 155 MIDDLE EAST: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 170 TABLE 156 GCC COUNTRIES: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2023–2033 (USD MILLION)) 170 TABLE 157 BEAD-BASED FLOW CYTOMETRY MARKET, BY REGION, 2023–2033 (USD MILLION) 172 TABLE 158 NORTH AMERICA: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 172 TABLE 159 EUROPE: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 173 TABLE 160 ASIA PACIFIC: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 173 TABLE 161 LATIN AMERICA: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 174 TABLE 162 MIDDLE EAST: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 174 TABLE 163 GCC COUNTRIES: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 174 TABLE 164 FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 176 TABLE 165 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 177 TABLE 166 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2023–2033 (USD MILLION) 177 TABLE 167 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2033 (USD MILLION) 178 TABLE 168 EUROPE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2033 (USD MILLION) 178 TABLE 169 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2033 (USD MILLION) 179 TABLE 170 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2033 (USD MILLION) 179 TABLE 171 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2033 (USD MILLION) 180 TABLE 172 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2033 (USD MILLION) 180 TABLE 173 DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 181 TABLE 174 DRUG DISCOVERY AND DEVELOPMENT MARKET, BY REGION, 2023–2033 (USD MILLION) 181 TABLE 175 NORTH AMERICA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 181 TABLE 176 EUROPE: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 182 TABLE 177 ASIA PACIFIC: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 182 TABLE 178 LATIN AMERICA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 183 TABLE 179 MIDDLE EAST: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 183 TABLE 180 GCC COUNTRIES: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 183 TABLE 181 DRUG DISCOVERY MARKET, BY REGION, 2023–2033 (USD MILLION) 185 TABLE 182 NORTH AMERICA: DRUG DISCOVERY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 185 TABLE 183 EUROPE: DRUG DISCOVERY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 186 TABLE 184 ASIA PACIFIC: DRUG DISCOVERY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 186 TABLE 185 LATIN AMERICA: DRUG DISCOVERY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 187 TABLE 186 MIDDLE EAST: DRUG DISCOVERY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 187 TABLE 187 GCC COUNTRIES: DRUG DISCOVERY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 187 TABLE 188 STEM CELL RESEARCH MARKET, BY REGION, 2023–2033 (USD MILLION) 189 TABLE 189 NORTH AMERICA: STEM CELL RESEARCH MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 189 TABLE 190 EUROPE: STEM CELL RESEARCH MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 190 TABLE 191 ASIA PACIFIC: STEM CELL RESEARCH MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 190 TABLE 192 LATIN AMERICA: STEM CELL RESEARCH MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 191 TABLE 193 MIDDLE EAST: STEM CELL RESEARCH MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 191 TABLE 194 GCC COUNTRIES: STEM CELL RESEARCH MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 191 TABLE 195 IN VITRO TOXICITY TESTING MARKET, BY REGION, 2023–2033 (USD MILLION) 192 TABLE 196 NORTH AMERICA: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 193 TABLE 197 EUROPE: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 193 TABLE 198 ASIA PACIFIC: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 194 TABLE 199 LATIN AMERICA: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 194 TABLE 200 MIDDLE EAST: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 195 TABLE 201 IMMUNOLOGY MARKET, BY REGION, 2023–2033 (USD MILLION) 196 TABLE 202 NORTH AMERICA: IMMUNOLOGY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 196 TABLE 203 EUROPE: IMMUNOLOGY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 197 TABLE 204 GCC COUNTRIES: IN VITRO TESTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 197 TABLE 205 ASIA PACIFIC: IMMUNOLOGY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 198 TABLE 206 LATIN AMERICA: IMMUNOLOGY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 198 TABLE 207 MIDDLE EAST: IMMUNOLOGY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 198 TABLE 208 GCC COUNTRIES: IMMUNOLOGY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 199 TABLE 209 CELL SORTING MARKET, BY REGION, 2023–2033 (USD MILLION) 200 TABLE 210 NORTH AMERICA: CELL SORTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 200 TABLE 211 EUROPE: CELL SORTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 201 TABLE 212 ASIA PACIFIC: CELL SORTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 201 TABLE 213 LATIN AMERICA: CELL SORTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 202 TABLE 214 MIDDLE EAST: CELL SORTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 202 TABLE 215 GCC COUNTRIES: CELL SORTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 202 TABLE 216 APOPTOSIS MARKET, BY REGION, 2023–2033 (USD MILLION) 203 TABLE 217 NORTH AMERICA: APOPTOSIS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 204 TABLE 218 EUROPE: APOPTOSIS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 204 TABLE 219 ASIA PACIFIC: APOPTOSIS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 205 TABLE 220 LATIN AMERICA: APOPTOSIS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 205 TABLE 221 MIDDLE EAST: APOPTOSIS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 206 TABLE 222 GCC COUNTRIES: APOPTOSIS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 206 TABLE 223 CELL CYCLE ANALYSIS MARKET, BY REGION, 2023–2033 (USD MILLION) 207 TABLE 224 NORTH AMERICA: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 207 TABLE 225 EUROPE: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 208 TABLE 226 ASIA PACIFIC: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 208 TABLE 227 LATIN AMERICA: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 209 TABLE 228 MIDDLE EAST: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 209 TABLE 229 GCC COUNTRIES: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 209 TABLE 230 CELL VIABILITY MARKET, BY REGION, 2023–2033 (USD MILLION) 210 TABLE 231 NORTH AMERICA: CELL VIABILITY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 211 TABLE 232 EUROPE: CELL VIABILITY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 211 TABLE 233 ASIA PACIFIC: CELL VIABILITY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 212 TABLE 234 LATIN AMERICA: CELL VIABILITY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 212 TABLE 235 MIDDLE EAST: CELL VIABILITY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 213 TABLE 236 GCC COUNTRIES: CELL VIABILITY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 213 TABLE 237 CELL COUNTING MARKET, BY REGION, 2023–2033 (USD MILLION) 214 TABLE 238 NORTH AMERICA: CELL COUNTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 214 TABLE 239 EUROPE: CELL COUNTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 215 TABLE 240 ASIA PACIFIC: CELL COUNTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 215 TABLE 241 LATIN AMERICA: CELL COUNTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 216 TABLE 242 MIDDLE EAST: CELL COUNTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 216 TABLE 243 GCC COUNTRIES: CELL COUNTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 216 TABLE 244 OTHER RESEARCH APPLICATIONS MARKET, BY REGION, 2023–2033 (USD MILLION) 217 TABLE 245 NORTH AMERICA: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 217 TABLE 246 EUROPE: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 218 TABLE 247 ASIA PACIFIC: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 218 TABLE 248 LATIN AMERICA: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 219 TABLE 249 MIDDLE EAST: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 219 TABLE 250 GCC COUNTRIES: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 219 TABLE 251 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 220 TABLE 252 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2023–2033 (USD MILLION) 221 TABLE 253 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2023–2033 (USD MILLION) 221 TABLE 254 EUROPE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2023–2033 (USD MILLION) 222 TABLE 255 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2023–2033 (USD MILLION) 222 TABLE 256 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2023–2033 (USD MILLION) 223 TABLE 257 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2023–2033 (USD MILLION) 223 TABLE 258 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2023–2033 (USD MILLION) 223 TABLE 259 ESTIMATED NUMBER OF NEW CANCER CASES (2020–2040) 224 TABLE 260 CANCER DIAGNOSTICS MARKET, BY REGION, 2023–2033 (USD MILLION) 225 TABLE 261 NORTH AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 225 TABLE 262 EUROPE: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 226 TABLE 263 ASIA PACIFIC: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 226 TABLE 264 LATIN AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 227 TABLE 265 MIDDLE EAST: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 227 TABLE 266 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR CANCER, BY COUNTRY, 2023–2033 (USD MILLION) 227 TABLE 267 HEMATOLOGY MARKET, BY REGION, 2023–2033 (USD MILLION) 228 TABLE 268 NORTH AMERICA: HEMATOLOGY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 229 TABLE 269 EUROPE: HEMATOLOGY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 229 TABLE 270 ASIA PACIFIC: HEMATOLOGY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 230 TABLE 271 LATIN AMERICA: HEMATOLOGY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 230 TABLE 272 MIDDLE EAST: HEMATOLOGY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 230 TABLE 273 GCC COUNTRIES: HEMATOLOGY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 231 TABLE 274 AUTOIMMUNE DISEASES MARKET, BY REGION, 2023–2033 (USD MILLION) 232 TABLE 275 NORTH AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 232 TABLE 276 EUROPE: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 233 TABLE 277 ASIA PACIFIC: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 233 TABLE 278 LATIN AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 234 TABLE 279 MIDDLE EAST: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 234 TABLE 280 GCC COUNTRIES: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 234 TABLE 281 ORGAN TRANSPLANTATION MARKET, BY REGION, 2023–2033 (USD MILLION) 236 TABLE 282 NORTH AMERICA: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 236 TABLE 283 EUROPE: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 237 TABLE 284 ASIA PACIFIC: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 237 TABLE 285 LATIN AMERICA: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 238 TABLE 286 MIDDLE EAST: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 238 TABLE 287 GCC COUNTRIES: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 238 TABLE 288 OTHER CLINICAL APPLICATIONS MARKET, BY REGION, 2023–2033 (USD MILLION) 239 TABLE 289 NORTH AMERICA: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 240 TABLE 290 EUROPE: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 240 TABLE 291 ASIA PACIFIC: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 241 TABLE 292 LATIN AMERICA: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 241 TABLE 293 MIDDLE EAST: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 242 TABLE 294 GCC COUNTRIES: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 242 TABLE 295 FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2023–2033 (USD MILLION) 243 TABLE 296 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2023–2033 (USD MILLION) 244 TABLE 297 EUROPE: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2023–2033 (USD MILLION) 244 TABLE 298 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2023–2033 (USD MILLION) 245 TABLE 299 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2023–2033 (USD MILLION) 245 TABLE 300 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2023–2033 (USD MILLION) 246 TABLE 301 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2023–2033 (USD MILLION) 246 TABLE 302 FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 248 TABLE 303 FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2033 (USD MILLION) 250 TABLE 304 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2033 (USD MILLION) 250 TABLE 305 EUROPE: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2033 (USD MILLION) 251 TABLE 306 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2033 (USD MILLION) 251 TABLE 307 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2033 (USD MILLION) 252 TABLE 308 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2033 (USD MILLION) 252 TABLE 309 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2033 (USD MILLION) 252 TABLE 310 FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2023–2033 (USD MILLION) 254 TABLE 311 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2023–2033 (USD MILLION) 254 TABLE 312 EUROPE: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2023–2033 (USD MILLION) 255 TABLE 313 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2023–2033 (USD MILLION) 255 TABLE 314 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2023–2033 (USD MILLION) 256 TABLE 315 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2023–2033 (USD MILLION) 256 TABLE 316 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2023–2033 (USD MILLION) 256 TABLE 317 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2033 (USD MILLION) 257 TABLE 318 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2033 (USD MILLION) 258 TABLE 319 EUROPE: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2033 (USD MILLION) 258 TABLE 320 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2033 (USD MILLION) 259 TABLE 321 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2033 (USD MILLION) 259 TABLE 322 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2033 (USD MILLION) 260 TABLE 323 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2033 (USD MILLION) 260 TABLE 324 FLOW CYTOMETRY MARKET, BY REGION, 2023–2033 (USD MILLION) 262 TABLE 325 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 264 TABLE 326 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 265 TABLE 327 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 265 TABLE 328 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 265 TABLE 329 NORTH AMERICA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 266 TABLE 330 NORTH AMERICA: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 266 TABLE 331 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 266 TABLE 332 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 267 TABLE 333 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 267 TABLE 334 NORTH AMERICA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 268 TABLE 335 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 268 TABLE 336 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 269 TABLE 337 US: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 270 TABLE 338 US: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 270 TABLE 339 US: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 271 TABLE 340 US: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 271 TABLE 341 US: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 271 TABLE 342 US: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 272 TABLE 343 US: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 272 TABLE 344 US: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 273 TABLE 345 US: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 273 TABLE 346 US: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 274 TABLE 347 US: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 274 TABLE 348 CANADA: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 275 TABLE 349 CANADA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 276 TABLE 350 CANADA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 276 TABLE 351 CANADA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 276 TABLE 352 CANADA: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 277 TABLE 353 CANADA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 277 TABLE 354 CANADA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 277 TABLE 355 CANADA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 278 TABLE 356 CANADA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 278 TABLE 357 CANADA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 279 TABLE 358 CANADA: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 279 TABLE 359 EUROPE: FLOW CYTOMETRY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 281 TABLE 360 EUROPE: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 281 TABLE 361 EUROPE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 282 TABLE 362 EUROPE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 282 TABLE 363 EUROPE: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 282 TABLE 364 EUROPE: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 283 TABLE 365 EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 283 TABLE 366 EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 283 TABLE 367 EUROPE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 284 TABLE 368 EUROPE: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 284 TABLE 369 EUROPE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 285 TABLE 370 EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 285 TABLE 371 GERMANY: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 286 TABLE 372 GERMANY: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 287 TABLE 373 GERMANY: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 287 TABLE 374 GERMANY: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 287 TABLE 375 GERMANY: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 288 TABLE 376 GERMANY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 288 TABLE 377 GERMANY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 288 TABLE 378 GERMANY: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 289 TABLE 379 GERMANY: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 289 TABLE 380 GERMANY: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 290 TABLE 381 GERMANY: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 290 TABLE 382 UK: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 291 TABLE 383 UK: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 292 TABLE 384 UK: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 292 TABLE 385 UK: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 292 TABLE 386 UK: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 293 TABLE 387 UK: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 293 TABLE 388 UK: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 293 TABLE 389 UK: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 294 TABLE 390 UK: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 294 TABLE 391 UK: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 295 TABLE 392 UK: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 295 TABLE 393 FRANCE: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 296 TABLE 394 FRANCE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 296 TABLE 395 FRANCE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 297 TABLE 396 FRANCE: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 297 TABLE 397 FRANCE: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 297 TABLE 398 FRANCE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 298 TABLE 399 FRANCE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 298 TABLE 400 FRANCE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 299 TABLE 401 FRANCE: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 299 TABLE 402 FRANCE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 300 TABLE 403 FRANCE: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 300 TABLE 404 ITALY: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 301 TABLE 405 ITALY: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 302 TABLE 406 ITALY: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 302 TABLE 407 ITALY: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 302 TABLE 408 ITALY: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 303 TABLE 409 ITALY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 303 TABLE 410 ITALY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 303 TABLE 411 ITALY: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 304 TABLE 412 ITALY: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 304 TABLE 413 ITALY: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 305 TABLE 414 ITALY: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 305 TABLE 415 SPAIN: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 306 TABLE 416 SPAIN: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 307 TABLE 417 SPAIN: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 307 TABLE 418 SPAIN: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 307 TABLE 419 SPAIN: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 308 TABLE 420 SPAIN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 308 TABLE 421 SPAIN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 308 TABLE 422 SPAIN: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 309 TABLE 423 SPAIN: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 309 TABLE 424 SPAIN: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 310 TABLE 425 SPAIN: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 310 TABLE 426 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 311 TABLE 427 REST OF EUROPE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 312 TABLE 428 REST OF EUROPE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 312 TABLE 429 REST OF EUROPE: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 312 TABLE 430 REST OF EUROPE: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 313 TABLE 431 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 313 TABLE 432 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 313 TABLE 433 REST OF EUROPE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 314 TABLE 434 REST OF EUROPE: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 314 TABLE 435 REST OF EUROPE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 315 TABLE 436 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 315 TABLE 437 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 318 TABLE 438 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 318 TABLE 439 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 319 TABLE 440 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 319 TABLE 441 ASIA PACIFIC: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 319 TABLE 442 ASIA PACIFIC: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 320 TABLE 443 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 320 TABLE 444 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 320 TABLE 445 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 321 TABLE 446 ASIA PACIFIC: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 321 TABLE 447 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 322 TABLE 448 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 322 TABLE 449 CHINA: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 323 TABLE 450 CHINA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 324 TABLE 451 CHINA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 324 TABLE 452 CHINA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 324 TABLE 453 CHINA: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 325 TABLE 454 CHINA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 325 TABLE 455 CHINA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 325 TABLE 456 CHINA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 326 TABLE 457 CHINA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 326 TABLE 458 CHINA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 327 TABLE 459 CHINA: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 327 TABLE 460 JAPAN: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 328 TABLE 461 JAPAN: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 329 TABLE 462 JAPAN: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 329 TABLE 463 JAPAN: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 329 TABLE 464 JAPAN: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 330 TABLE 465 JAPAN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 330 TABLE 466 JAPAN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 330 TABLE 467 JAPAN: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 331 TABLE 468 JAPAN: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 331 TABLE 469 JAPAN: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 332 TABLE 470 JAPAN: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 332 TABLE 471 INDIA: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 334 TABLE 472 INDIA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 334 TABLE 473 INDIA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 334 TABLE 474 INDIA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 335 TABLE 475 INDIA: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 335 TABLE 476 INDIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 335 TABLE 477 INDIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 336 TABLE 478 INDIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 336 TABLE 479 INDIA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 337 TABLE 480 INDIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 337 TABLE 481 INDIA: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 338 TABLE 482 AUSTRALIA: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 339 TABLE 483 AUSTRALIA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 339 TABLE 484 AUSTRALIA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 340 TABLE 485 AUSTRALIA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 340 TABLE 486 AUSTRALIA: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 340 TABLE 487 AUSTRALIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 341 TABLE 488 AUSTRALIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 341 TABLE 489 AUSTRALIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 342 TABLE 490 AUSTRALIA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 342 TABLE 491 AUSTRALIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 343 TABLE 492 AUSTRALIA: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 343 TABLE 493 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 344 TABLE 494 SOUTH KOREA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 344 TABLE 495 SOUTH KOREA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 345 TABLE 496 SOUTH KOREA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 345 TABLE 497 SOUTH KOREA: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 345 TABLE 498 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 346 TABLE 499 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 346 TABLE 500 SOUTH KOREA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 347 TABLE 501 SOUTH KOREA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 347 TABLE 502 SOUTH KOREA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 348 TABLE 503 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 348 TABLE 504 SINGAPORE: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 350 TABLE 505 SINGAPORE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 350 TABLE 506 SINGAPORE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 350 TABLE 507 SINGAPORE: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 351 TABLE 508 SINGAPORE: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 351 TABLE 509 SINGAPORE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 351 TABLE 510 SINGAPORE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 352 TABLE 511 SINGAPORE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 352 TABLE 512 SINGAPORE: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 353 TABLE 513 SINGAPORE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 353 TABLE 514 SINGAPORE: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 354 TABLE 515 INDONESIA: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 355 TABLE 516 INDONESIA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 355 TABLE 517 INDONESIA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 356 TABLE 518 INDONESIA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 356 TABLE 519 INDONESIA: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 356 TABLE 520 INDONESIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 357 TABLE 521 INDONESIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 357 TABLE 522 INDONESIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 358 TABLE 523 INDONESIA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 358 TABLE 524 INDONESIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 359 TABLE 525 INDONESIA: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 359 TABLE 526 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 360 TABLE 527 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 360 TABLE 528 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 361 TABLE 529 REST OF ASIA PACIFIC: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 361 TABLE 530 REST OF ASIA PACIFIC: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 361 TABLE 531 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 362 TABLE 532 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 362 TABLE 533 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 363 TABLE 534 REST OF ASIA PACIFIC: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 363 TABLE 535 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 364 TABLE 536 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 364 TABLE 537 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 365 TABLE 538 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 366 TABLE 539 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 366 TABLE 540 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 366 TABLE 541 LATIN AMERICA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 367 TABLE 542 LATIN AMERICA: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 367 TABLE 543 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 367 TABLE 544 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 368 TABLE 545 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 368 TABLE 546 LATIN AMERICA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 369 TABLE 547 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 369 TABLE 548 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 370 TABLE 549 BRAZIL: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 371 TABLE 550 BRAZIL: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 371 TABLE 551 BRAZIL: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 371 TABLE 552 BRAZIL: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 372 TABLE 553 BRAZIL: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 372 TABLE 554 BRAZIL: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 372 TABLE 555 BRAZIL: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 373 TABLE 556 BRAZIL: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 373 TABLE 557 BRAZIL: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 374 TABLE 558 BRAZIL: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 374 TABLE 559 BRAZIL: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 375 TABLE 560 MEXICO: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 376 TABLE 561 MEXICO: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 376 TABLE 562 MEXICO: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 376 TABLE 563 MEXICO: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 377 TABLE 564 MEXICO: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 377 TABLE 565 MEXICO: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 377 TABLE 566 MEXICO: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 378 TABLE 567 MEXICO: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 378 TABLE 568 MEXICO: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 379 TABLE 569 MEXICO: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 379 TABLE 570 MEXICO: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 380 TABLE 571 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 381 TABLE 572 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 381 TABLE 573 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 381 TABLE 574 REST OF LATIN AMERICA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 382 TABLE 575 REST OF LATIN AMERICA: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 382 TABLE 576 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 382 TABLE 577 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 383 TABLE 578 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 383 TABLE 579 REST OF LATIN AMERICA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 384 TABLE 580 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 384 TABLE 581 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 385 TABLE 582 MIDDLE EAST: FLOW CYTOMETRY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 386 TABLE 583 MIDDLE EAST: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 386 TABLE 584 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 387 TABLE 585 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 387 TABLE 586 MIDDLE EAST: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 387 TABLE 587 MIDDLE EAST: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 388 TABLE 588 MIDDLE EAST: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 388 TABLE 589 MIDDLE EAST: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 388 TABLE 590 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 389 TABLE 591 MIDDLE EAST: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 389 TABLE 592 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 390 TABLE 593 MIDDLE EAST: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 390 TABLE 594 GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY COUNTRY, 2023–2033 (USD MILLION) 391 TABLE 595 GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 391 TABLE 596 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 392 TABLE 597 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 392 TABLE 598 GCC COUNTRIES: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 392 TABLE 599 GCC COUNTRIES: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 393 TABLE 600 GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 393 TABLE 601 GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 393 TABLE 602 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 394 TABLE 603 GCC COUNTRIES: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 394 TABLE 604 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 395 TABLE 605 GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 395 TABLE 606 SAUDI ARABIA: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 396 TABLE 607 SAUDI ARABIA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 396 TABLE 608 SAUDI ARABIA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 397 TABLE 609 SAUDI ARABIA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 397 TABLE 610 SAUDI ARABIA: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 397 TABLE 611 SAUDI ARABIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 398 TABLE 612 SAUDI ARABIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 398 TABLE 613 SAUDI ARABIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 399 TABLE 614 SAUDI ARABIA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 399 TABLE 615 SAUDI ARABIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 400 TABLE 616 SAUDI ARABIA: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 400 TABLE 617 UAE: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 401 TABLE 618 UAE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 402 TABLE 619 UAE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 402 TABLE 620 UAE: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 402 TABLE 621 UAE: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 403 TABLE 622 UAE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 403 TABLE 623 UAE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 403 TABLE 624 UAE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 404 TABLE 625 UAE: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 404 TABLE 626 UAE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 405 TABLE 627 UAE: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 405 TABLE 628 REST OF GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 406 TABLE 629 REST OF GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 407 TABLE 630 REST OF GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 407 TABLE 631 REST OF GCC COUNTRIES: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 407 TABLE 632 REST OF GCC COUNTRIES: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 408 TABLE 633 REST OF GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 408 TABLE 634 REST OF GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 408 TABLE 635 REST OF GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 409 TABLE 636 REST OF GCC COUNTRIES: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 409 TABLE 637 REST OF GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 410 TABLE 638 REST OF GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 410 TABLE 639 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 411 TABLE 640 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 411 TABLE 641 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 412 TABLE 642 REST OF MIDDLE EAST: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 412 TABLE 643 REST OF MIDDLE EAST: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 412 TABLE 644 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 413 TABLE 645 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 413 TABLE 646 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 414 TABLE 647 REST OF MIDDLE EAST: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 414 TABLE 648 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 415 TABLE 649 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 415 TABLE 650 AFRICA: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION) 417 TABLE 651 AFRICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 417 TABLE 652 AFRICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION) 417 TABLE 653 AFRICA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 418 TABLE 654 AFRICA: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION) 418 TABLE 655 AFRICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION) 418 TABLE 656 AFRICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION) 419 TABLE 657 AFRICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 419 TABLE 658 AFRICA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION) 420 TABLE 659 AFRICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 420 TABLE 660 AFRICA: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION) 421 TABLE 661 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN FLOW CYTOMETRY MARKET 422 TABLE 662 FLOW CYTOMETRY MARKET: DEGREE OF COMPETITION 425 TABLE 663 FLOW CYTOMETRY MARKET: PRODUCT & SERVICE FOOTPRINT 430 TABLE 664 FLOW CYTOMETRY MARKET: REGION FOOTPRINT 431 TABLE 665 FLOW CYTOMETRY MARKET: APPLICATION FOOTPRINT 432 TABLE 666 FLOW CYTOMETRY MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 434 TABLE 667 FLOW CYTOMETRY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 435 TABLE 668 FLOW CYTOMETRY MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 439 TABLE 669 FLOW CYTOMETRY MARKET: DEALS, JANUARY 2022–MAY 2025 440 TABLE 670 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 441 TABLE 671 BECTON, DICKINSON AND COMPANY: PRODUCTS/SERVICES OFFERED 442 TABLE 672 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025 446 TABLE 673 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–MAY 2025 447 TABLE 674 DANAHER CORPORATION: COMPANY OVERVIEW 449 TABLE 675 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED 451 TABLE 676 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025 453 TABLE 677 DANAHER CORPORATION: DEALS, JANUARY 2021–MAY 2025 453 TABLE 678 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 455 TABLE 679 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 456 TABLE 680 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025 457 TABLE 681 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–MAY 2025 458 TABLE 682 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 459 TABLE 683 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED 461 TABLE 684 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025 462 TABLE 685 SONY CORPORATION: COMPANY OVERVIEW 463 TABLE 686 SONY CORPORATION: PRODUCTS/SERVICES OFFERED 464 TABLE 687 SONY CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025 466 TABLE 688 SONY CORPORATION: DEALS, JANUARY 2021–MAY 2025 466 TABLE 689 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 467 TABLE 690 BIO-RAD LABORATORIES, INC.: PRODUCTS/ SERVICES/SOLUTIONS OFFERED 468 TABLE 691 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025 469 TABLE 692 MILTENYI BIOTEC: COMPANY OVERVIEW 470 TABLE 693 MILTENYI BIOTEC.: PRODUCTS/ SERVICES OFFERED 470 TABLE 694 ENZO BIOCHEM INC.: COMPANY OVERVIEW 472 TABLE 695 ENZO BIOCHEM INC.: PRODUCTS/SERVICES OFFERED 473 TABLE 696 SYSMEX CORPORATION: COMPANY OVERVIEW 475 TABLE 697 SYSMEX CORPORATION: PRODUCTS/SERVICES OFFERED 477 TABLE 698 SYSMEX CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025 477 TABLE 699 CYTEK BIOSCIENCES: COMPANY OVERVIEW 478 TABLE 700 CYTEK BIOSCIENCES: PRODUCTS/ SERVICES OFFERED 480 TABLE 701 CYTEK BIOSCIENCES: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025 481 TABLE 702 CYTEK BIOSCIENCES: DEALS, JANUARY 2021–MAY 2025 481 TABLE 703 BIOMÉRIEUX: COMPANY OVERVIEW 483 TABLE 704 BIOMÉRIEUX: PRODUCTS/SERVICES OFFERED 484 TABLE 705 CYTONOME/ST, LLC: COMPANY OVERVIEW 485 TABLE 706 CYTONOME/ST, LLC: PRODUCTS/ SERVICES OFFERED 485 TABLE 707 SARTORIUS AG: COMPANY OVERVIEW 486 TABLE 708 SARTORIUS AG: PRODUCTS/ SERVICES OFFERED 487 TABLE 709 UNION BIOMETRICA, INC.: COMPANY OVERVIEW 488 TABLE 710 UNION BIOMETRICA, INC.: PRODUCTS/ SERVICES OFFERED 488 TABLE 711 TAKARA BIO INC.: COMPANY OVERVIEW 489 TABLE 712 TAKARA BIO INC.: PRODUCTS/ SERVICES OFFERED 491 TABLE 713 APOGEE FLOW SYSTEMS LTD.: COMPANY OVERVIEW 492 TABLE 714 STRATEDIGM, INC.: COMPANY OVERVIEW 493 TABLE 715 NANOCELLECT BIOMEDICAL: COMPANY OVERVIEW 494 TABLE 716 BIOLEGEND, INC.: COMPANY OVERVIEW 495 TABLE 717 ON-CHIP BIOTECHNOLOGIES CO., LTD.: COMPANY OVERVIEW 496 TABLE 718 NEXCELOM BIOSCIENCE LLC: COMPANY OVERVIEW 497 TABLE 719 BENNUBIO INC.: COMPANY OVERVIEW 498 TABLE 720 ORFLO TECHNOLOGIES: COMPANY OVERVIEW 499 TABLE 721 BAY BIOSCIENCE LLC: COMPANY OVERVIEW 500 TABLE 722 CYTOBUOY: COMPANY OVERVIEW 500 FIGURE 1 FLOW CYTOMETRY MARKET: SEGMENTS COVERED 46 FIGURE 2 FLOW CYTOMETRY MARKET: YEARS CONSIDERED 47 FIGURE 3 FLOW CYTOMETRY MARKET: RESEARCH DESIGN 49 FIGURE 4 FLOW CYTOMETRY MARKET: BREAKDOWN OF PRIMARIES 51 FIGURE 5 FLOW CYTOMETRY MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024 52 FIGURE 6 GLOBAL MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH), 2024 53 FIGURE 7 ILLUSTRATIVE EXAMPLE OF BECTON, DICKINSON AND COMPANY: REVENUE ANALYSIS (2024) 53 FIGURE 8 MARKET VALIDATION FROM PRIMARY EXPERTS 55 FIGURE 9 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 55 FIGURE 10 FLOW CYTOMETRY MARKET: CAGR PROJECTIONS, 2025–2033 57 FIGURE 11 FLOW CYTOMETRY MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 58 FIGURE 12 DATA TRIANGULATION METHODOLOGY 59 FIGURE 13 FLOW CYTOMETRY MARKET, BY OFFERING, 2025 VS. 2033 (USD MILLION) 62 FIGURE 14 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2025 VS. 2033 (USD MILLION) 63 FIGURE 15 FLOW CYTOMETRY MARKET, BY APPLICATION, 2025 VS. 2033 (USD MILLION) 63 FIGURE 16 FLOW CYTOMETRY MARKET, BY END USER, 2025 VS. 2033 (USD MILLION) 64 FIGURE 17 FLOW CYTOMETRY MARKET: GEOGRAPHIC ANALYSIS 65 FIGURE 18 LAUNCH OF TECHNOLOGICALLY ADVANCED FLOW CYTOMETRY PRODUCTS TO DRIVE MARKET 66 FIGURE 19 CELL-BASED FLOW CYTOMETRY ACCOUNTED FOR LARGER SHARE OF MARKET IN NORTH AMERICA IN 2024 67 FIGURE 20 ACADEMIC & RESEARCH INSTITUTES TO LEAD MARKET DURING FORECAST PERIOD 67 FIGURE 21 CHINA TO BE FASTEST-GROWING COUNTRY-LEVEL MARKET DURING FORECAST PERIOD 68 FIGURE 22 FLOW CYTOMETRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 69 FIGURE 23 RISING USE OF FLOW CYTOMETRY IN CLINICAL APPLICATIONS 76 FIGURE 24 AVERAGE SELLING PRICE OF REAGENTS AND CONSUMABLES, BY KEY PLAYER, 2024 (USD) 78 FIGURE 25 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2024 (USD) 78 FIGURE 26 AVERAGE SELLING PRICE OF INSTRUMENTS, BY REGION, 2024 (USD MILLION) 79 FIGURE 27 AVERAGE SELLING PRICE OF REAGENTS AND CONSUMABLES, BY REGION, 2024 (USD MILLION) 80 FIGURE 28 FLOW CYTOMETRY MARKET: VALUE CHAIN ANALYSIS 81 FIGURE 29 FLOW CYTOMETRY MARKET: ECOSYSTEM ANALYSIS 83 FIGURE 30 FLOW CYTOMETRY MARKET: PORTER’S FIVE FORCES ANALYSIS 89 FIGURE 31 FLOW CYTOMETRY MARKET: INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 92 FIGURE 32 FLOW CYTOMETRY MARKET: KEY BUYING CRITERIA, BY END USER 93 FIGURE 33 PATENT APPLICATIONS IN FLOW CYTOMETRY MARKET, JANUARY 2014–DECEMBER 2024 97 FIGURE 34 FUNDING AND NUMBER OF DEALS IN FLOW CYTOMETRY MARKET, 2022–2025 101 FIGURE 35 FLOW CYTOMETRY MARKET: AI USE CASES 108 FIGURE 36 NUMBER OF ORGAN TRANSPLANTS IN US (2024) 235 FIGURE 37 NORTH AMERICA: FLOW CYTOMETRY MARKET SNAPSHOT 264 FIGURE 38 ASIA PACIFIC: FLOW CYTOMETRY MARKET SNAPSHOT 317 FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN FLOW CYTOMETRY MARKET, 2022–2024 (USD MILLION) 424 FIGURE 40 FLOW CYTOMETRY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2024 425 FIGURE 41 FLOW CYTOMETRY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 428 FIGURE 42 FLOW CYTOMETRY MARKET: COMPANY FOOTPRINT 429 FIGURE 43 FLOW CYTOMETRY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 433 FIGURE 44 EV/EBITDA OF KEY PLAYERS 436 FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY PLAYERS 436 FIGURE 46 FLOW CYTOMETRY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS OF CELL SORTERS 437 FIGURE 47 FLOW CYTOMETRY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS OF CELL ANALYZERS 438 FIGURE 48 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2024) 442 FIGURE 49 DANAHER CORPORATION: COMPANY SNAPSHOT (2024) 450 FIGURE 50 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 456 FIGURE 51 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024) 460 FIGURE 52 SONY CORPORATION: COMPANY SNAPSHOT (2024) 464 FIGURE 53 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 468 FIGURE 54 ENZO BIOCHEM INC.: COMPANY SNAPSHOT (2024) 472 FIGURE 55 SYSMEX CORPORATION: COMPANY SNAPSHOT (2024) 476 FIGURE 56 CYTEK BIOSCIENCES: COMPANY SNAPSHOT (2024) 479 FIGURE 57 BIOMÉRIEUX: COMPANY SNAPSHOT (2024) 484 FIGURE 58 SARTORIUS AG: COMPANY SNAPSHOT (2024) 487 FIGURE 59 TAKARA BIO INC.: COMPANY SNAPSHOT (2024) 490

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們